305 related articles for article (PubMed ID: 12227607)
1. From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas.
Heberer T; Reddersen K; Mechlinski A
Water Sci Technol; 2002; 46(3):81-8. PubMed ID: 12227607
[TBL] [Abstract][Full Text] [Related]
2. Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration.
Petrovic M; de Alda MJ; Diaz-Cruz S; Postigo C; Radjenovic J; Gros M; Barcelo D
Philos Trans A Math Phys Eng Sci; 2009 Oct; 367(1904):3979-4003. PubMed ID: 19736231
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
4. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
Radjenović J; Petrović M; Barceló D
Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
[TBL] [Abstract][Full Text] [Related]
5. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant.
Stackelberg PE; Furlong ET; Meyer MT; Zaugg SD; Henderson AK; Reissman DB
Sci Total Environ; 2004 Aug; 329(1-3):99-113. PubMed ID: 15262161
[TBL] [Abstract][Full Text] [Related]
6. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data.
Heberer T
Toxicol Lett; 2002 May; 131(1-2):5-17. PubMed ID: 11988354
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the fate of sulfonamides downgradient of a decommissioned sewage farm near Berlin, Germany.
Richter D; Massmann G; Taute T; Duennbier U
J Contam Hydrol; 2009 May; 106(3-4):183-94. PubMed ID: 19371963
[TBL] [Abstract][Full Text] [Related]
8. Diffuse pollution of surface water by pharmaceutical products.
Derksen JG; Rijs GB; Jongbloed RH
Water Sci Technol; 2004; 49(3):213-21. PubMed ID: 15053118
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada.
Boyd GR; Reemtsma H; Grimm DA; Mitra S
Sci Total Environ; 2003 Jul; 311(1-3):135-49. PubMed ID: 12826389
[TBL] [Abstract][Full Text] [Related]
10. Identification and significance of sulphonamides (p-TSA, o-TSA, BSA) in an urban water cycle (Berlin, Germany).
Richter D; Massmann G; Dünnbier U
Water Res; 2008 Mar; 42(6-7):1369-78. PubMed ID: 17961628
[TBL] [Abstract][Full Text] [Related]
11. Occurrence and distribution of psychoactive compounds and their metabolites in the urban water cycle of Berlin (Germany).
Hass U; Duennbier U; Massmann G
Water Res; 2012 Nov; 46(18):6013-22. PubMed ID: 22967903
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo River system (Madrid, Spain) and a potential risk characterization.
Fernández C; González-Doncel M; Pro J; Carbonell G; Tarazona JV
Sci Total Environ; 2010 Jan; 408(3):543-51. PubMed ID: 19889447
[TBL] [Abstract][Full Text] [Related]
13. Drugs, diagnostic agents and disinfectants in wastewater and water--a review.
Kümmerer K
Schriftenr Ver Wasser Boden Lufthyg; 2000; 105():59-71. PubMed ID: 10842795
[TBL] [Abstract][Full Text] [Related]
14. Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment.
Strenn B; Clara M; Gans O; Kreuzinger N
Water Sci Technol; 2004; 50(5):269-76. PubMed ID: 15497857
[TBL] [Abstract][Full Text] [Related]
15. Polar pollutants in municipal wastewater and the water cycle: occurrence and removal of benzotriazoles.
Reemtsma T; Miehe U; Duennbier U; Jekel M
Water Res; 2010 Jan; 44(2):596-604. PubMed ID: 19666184
[TBL] [Abstract][Full Text] [Related]
16. Determination of polar drug residues in sewage and surface water applying liquid chromatography-tandem mass spectrometry.
Zuehlke S; Duennbier U; Heberer T
Anal Chem; 2004 Nov; 76(22):6548-54. PubMed ID: 15538775
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
[TBL] [Abstract][Full Text] [Related]
18. Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents--modeling versus measurements.
Heberer T; Feldmann D
J Hazard Mater; 2005 Jul; 122(3):211-8. PubMed ID: 15967276
[TBL] [Abstract][Full Text] [Related]
19. Occurrence and fate of bulk organic matter and pharmaceutically active compounds in managed aquifer recharge: a review.
Maeng SK; Sharma SK; Lekkerkerker-Teunissen K; Amy GL
Water Res; 2011 May; 45(10):3015-33. PubMed ID: 21489592
[TBL] [Abstract][Full Text] [Related]
20. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater.
Kreuzinger N; Clara M; Strenn B; Kroiss H
Water Sci Technol; 2004; 50(5):149-56. PubMed ID: 15497842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
